AMPFX
Price
$44.41
Change
-$0.13 (-0.29%)
Updated
Aug 7 closing price
Net Assets
93.92B
GFACX
Price
$71.38
Change
-$0.14 (-0.20%)
Updated
Aug 7 closing price
Net Assets
324.74B
Interact to see
Advertisement

AMPFX vs GFACX

Header iconAMPFX vs GFACX Comparison
Open Charts AMPFX vs GFACXBanner chart's image
American Funds AMCAP F1
Price$44.41
Change-$0.13 (-0.29%)
VolumeN/A
Net Assets93.92B
American Funds Growth Fund of Amer C
Price$71.38
Change-$0.14 (-0.20%)
VolumeN/A
Net Assets324.74B
AMPFX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AMPFX vs. GFACX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPFX is a Buy and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 325B vs. AMPFX (93.9B). AMPFX pays higher dividends than GFACX: AMPFX (0.29) vs GFACX (0.00). AMPFX was incepted earlier than GFACX: AMPFX (24 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than AMPFX (0.70). AMPFX is a more actively managed with annual turnover of: 36.00 vs. GFACX (25.00). AMPFX (250) and GFACX (250) have matching initial minimum investment requirements. GFACX annual gain was more profitable for investors over the last year : 19.28 vs. AMPFX (12.38). GFACX return over 5 years is better than : 32.87 vs. AMPFX (26.76).
AMPFXGFACXAMPFX / GFACX
Total Expense Ratio0.701.3651%
Annual Report Gross Expense Ratio0.701.3651%
Fund Existence24 years24 years-
Gain YTD5.31211.95144%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets93.9B325B29%
Annual Yield % from dividends0.290.00-
Returns for 1 year12.3819.2864%
Returns for 3 years36.0738.9893%
Returns for 5 years26.7632.8781%
Returns for 10 years57.7665.3188%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITOS10.120.01
+0.15%
iTeos Therapeutics
EXEL37.39-0.32
-0.85%
Exelixis
AIM2.72-0.06
-2.16%
AIM ImmunoTech Inc
VTSI6.97-0.23
-3.19%
VirTra
TWST25.00-0.90
-3.47%
Twist Bioscience Corp